Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Camille L. Bedrosian currently holds 175,756 shares of Ultragenyx Pharmaceutical Inc. (RARE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Camille L. Bedrosian has been a net seller of RARE stock. They have purchased $0 and sold $6.3M worth of shares.
Camille L. Bedrosian's most recent insider trade was on Dec 1, 2025, when they sold 6,580 shares at $14.35 per share.
Camille L. Bedrosian serves as Executive at Ultragenyx Pharmaceutical Inc. (RARE). They have executed 42 insider transactions totaling $6.3M over their tenure at the company.
Camille L. Bedrosian holds the position of Executive at Ultragenyx Pharmaceutical Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Camille L. Bedrosian has shown a selling trading pattern, with $0 in total purchases and $6.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Camille L. Bedrosian was on Jan 15, 2021, when they sold $3.5M worth of RARE shares. This transaction involved 25,000 shares at $139.18 per share.
Camille L. Bedrosian currently owns 175,756 shares of Ultragenyx Pharmaceutical Inc. (RARE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Camille L. Bedrosian's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Camille L. Bedrosian has 42 Form 4 filings on record as an insider at Ultragenyx Pharmaceutical Inc..
Set alerts for Camille L. Bedrosian and 40,000+ other insiders.